Bank Of New York Mellon Corp Roivant Sciences Ltd. Call Options Transaction History
Bank Of New York Mellon Corp
- $528 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ROIV
# of Institutions
308Shares Held
496MCall Options Held
989KPut Options Held
1.15M-
Sb Investment Advisers (Uk) LTD London, X071.4MShares$856 Million6.97% of portfolio
-
Viking Global Investors LP69.2MShares$830 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$801 Million72.99% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$424 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.3MShares$352 Million0.02% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.45B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...